Lubiprostone

Lubiprostone is a medication used in the management of idiopathic chronic constipation. A prostaglandin E1 derivative, lubiprostone is a bicyclic fatty acid that activates ClC-2 chloride channels located on the apical side of the gastrointestinal epithelial cells. Activation of these channels promotes the secretion of a chloride-rich fluid that soften the stool, increase gastrointestinal motility, and induce spontaneous bowel movements (SBM). It is grouped under the following drug class(es): Prokinetic agents and Prostaglandins. Its therapeutic use is listed as gastrointestinal agents and laxatives. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Lubiprostone hemiketal and Lubiprostona. Its PubChem CID is 157920.

CAS No 333963-40-9
Molecular Formula C20H32F2O5
Molecular Weight 390.5 g/mol
Synonyms 7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid

Frequently Asked Questions